{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T19:09:11Z","timestamp":1788030551815,"version":"build-2784847793"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ70071"],"award-info":[{"award-number":["2022JJ70071"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/13696998.2024.2403940","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T03:45:08Z","timestamp":1726199108000},"page":"1180-1189","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Short- and long-term cost-effectiveness of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis in China"],"prefix":"10.1080","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5763-3488","authenticated-orcid":false,"given":"Yin","family":"Shi","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Xiangya Hospital Central South University","place":["Changsha, China"]},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwu","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University","place":["Changsha, China"]},{"name":"Department of Thoracic Surgery, Xiangya Hospital Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuishi","family":"Li","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University","place":["Changsha, China"]},{"name":"Department of General Surgery, Xiangya Hospital Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"China Center for Health Economic Research, Peking University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Xiangya Hospital Central South University","place":["Changsha, China"]},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital Central South University","place":["Changsha, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31286-1"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206145"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep29751"},{"issue":"1","key":"e_1_3_5_5_1","first-page":"29","article-title":"Survey on the prevalence of childhood atopic dermatitis in ten cities of China","volume":"37","author":"Heng G","year":"2004","unstructured":"Heng G, Liping Y, Yongsheng L, et\u00a0al. Survey on the prevalence of childhood atopic dermatitis in ten cities of China. Chin J Dermatol. 2004;37(1):29\u201331.","journal-title":"Chin J Dermatol"},{"issue":"32","key":"e_1_3_5_6_1","first-page":"2465","article-title":"The status and prospects of studies about atopic dermatitis","volume":"103","author":"Hao F","year":"2023","unstructured":"Hao F, Zhang JZ. The status and prospects of studies about atopic dermatitis. Zhonghua Yi Xue Za Zhi. 2023;103(32):2465\u20132469.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19580"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.3336"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.10.043"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314768"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/derm.2022.0094"},{"issue":"2","key":"e_1_3_5_12_1","first-page":"97","article-title":"Expert consensus on the application and management of therapeutic drugs for atopic dermatitis","volume":"57","author":"China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China. International Exchange and Promotive Association for Medical and Health Care","year":"2024","unstructured":"China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China. International Exchange and Promotive Association for Medical and Health Care., et\u00a0al. Expert consensus on the application and management of therapeutic drugs for atopic dermatitis. Chin J Dermatol. 2024;57(2):97\u2013108.","journal-title":"Chin J Dermatol"},{"issue":"4","key":"e_1_3_5_13_1","first-page":"449","article-title":"Research progress of drugs for the treatment of atopic dermatitis","volume":"33","author":"Rui Z","year":"2024","unstructured":"Rui Z, Juan L, Jinsong L. Research progress of drugs for the treatment of atopic dermatitis. Chin J Pharmacoepidemiol. 2024;33(4):449\u2013460.","journal-title":"Chin J Pharmacoepidemiol"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00266-6"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.08.102"},{"key":"e_1_3_5_16_1","unstructured":"National Healthcare Security Administration. Notice on the Issuance of the \u2018'National Basic Medical Insurance Work-related Injury Insurance and Maternity Insurance Drug Catalogue; 2023 [cited 2024 Sep 4]. Available from: https:\/\/www.nhsa.gov.cn\/art\/2023\/12\/13\/art_104_11673.html."},{"key":"e_1_3_5_17_1","unstructured":"Hunan Healthcare Security Administration. Hunan province implementation rules for the interim measures for the administration of basic medical insurance drugs; 2024 [cited 2024 Sep 4]. Available from: http:\/\/ybj.hunan.gov.cn\/ybj\/first113541\/firstF\/f2113606\/202202\/t20220210_22479785.html."},{"key":"e_1_3_5_18_1","unstructured":"The State Council The People\u2019s Republic of China. Interim measures for the administration of basic medical insurance drugs; 2024 [cited 2024 Sep 4]. Available from: https:\/\/www.gov.cn\/zhengce\/zhengceku\/2020-08\/04\/content_5532409.htm."},{"key":"e_1_3_5_19_1","unstructured":"Hunan Healthcare Security Administration. National drug list for basic medical insurance work injury insurance and maternity insurance; 2023 [cited 2024 Sep 4]. Available from: https:\/\/ybj.hunan.gov.cn\/ybj\/first113541\/firstF\/f2113606\/202312\/t20231229_32614511.html."},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01199-0"},{"key":"e_1_3_5_21_1","unstructured":"National Bureau of Statistics. National data; [cited 2024 Sep 4]. Available from: https:\/\/data.stats.gov.cn\/easyquery.htm?cn=C01."},{"key":"e_1_3_5_22_1","unstructured":"National Institute for Health and Care Excellence. Dupilumab for treating moderate to severe atopic dermatitis: technology appraisal guidance; 2018 [cited 2024 June 15]. Available from: https:\/\/www.nice.org.uk\/guidance\/TA534."},{"key":"e_1_3_5_23_1","unstructured":"Canadian Agency for Drugs & Technologies in Health. Pharmacoeconomic review report for dupixent; 2018. Available from: https:\/\/www.cadth.ca\/sites\/default\/files\/cdr\/pharmacoeconomic\/SR0533_Dupixent_PE_Report.pdf."},{"key":"e_1_3_5_24_1","unstructured":"Chinese Pharmaceutical Association. China guidelines for pharmcoeconomic evaluation 2020; 2020 [cited 2024 June 15]. Available from: https:\/\/www.ispor.org\/heor-resources\/more-heor-resources\/pharmacoeconomic-quidelines\/pe-quideline-detail\/china-mainland."},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3751"},{"key":"e_1_3_5_26_1","unstructured":"Institute for Clinical and Economic Review. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value; 2024 [cited June 15]. Available from: https:\/\/icer.org\/wp-content\/uploads\/2021\/08\/Atopic-Dermatitis_Final-Evidence-Report_081721.pdf."},{"key":"e_1_3_5_27_1","unstructured":"Institute for Clinical and Economic Review. Dupilumab and crisaborole for atopic dermatitis: effectiveness and value; 2024 [cited June 15]. Available from: https:\/\/icer.org\/wp-content\/uploads\/2020\/10\/MWCEPAC_ATOPIC_EVIDENCE_REPORT_051217.pdf."},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-023-00459-2"},{"key":"e_1_3_5_29_1","unstructured":"World Health Organization. Life tables by country. 2024 [cited 2024 June 15]. Available from: https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/gho-ghe-life-tables-by-country."},{"key":"e_1_3_5_30_1","unstructured":"Pharmaceutical Procurement System of Hunan Province; 2024 [cited 2024 June 15]. Available from: https:\/\/tps.ybj.hunan.gov.cn\/tps-local\/index."},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01733-7"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15688"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-019-00288-x"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00308-w"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02499-1"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-017-0201-6"},{"key":"e_1_3_5_37_1","unstructured":"National Bureau of Statistics of China. Health care and personal articles of consumer price indices ; 2022 [cited 2024 June 15]. Available from: http:\/\/data.stats.gov.cn\/search.htm?s=CPI."},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.3023"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2022.28.1.108"},{"key":"e_1_3_5_40_1","unstructured":"Atlas S Brouwer E Fox G et\u00a0al. Institute for clinical and economic review; JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value; evidence report ; 2021 [cited 2024 June 15]. Available from: https:\/\/icer.org\/wp-content\/uploads\/2020\/12\/Atopic-Dermatitis_Final-Evidence-Report_081721.pdf."},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2008.00489.x"},{"key":"e_1_3_5_42_1","unstructured":"National Healthcare Security Administration. National Basic Medical Insurance Work-Related Injury Insurance and Maternity Insurance Drug Catalogue ; 2020 [cited 2024 June 15]. Available from: http:\/\/www.nhsa.gov.cn\/art\/2020\/12\/28\/art_53_4223.html."},{"key":"e_1_3_5_43_1","unstructured":"National Healthcare Security Administration. National Basic Medical Insurance Work-related Injury Insurance and Maternity Insurance Drug Catalogue; 2022 [cited 2024 June 15]. Available from: http:\/\/www.nhsa.gov.cn\/art\/2023\/1\/18\/art_104_10078.html."},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03577.x"},{"issue":"01","key":"e_1_3_5_45_1","first-page":"36","article-title":"On the quality of life and economic burden of psoriasis and eczema patients","volume":"13","author":"Wan Y","year":"2013","unstructured":"Wan Y, Shi G, Feng T, et\u00a0al. On the quality of life and economic burden of psoriasis and eczema patients. Acta University Medicinals Nanjing (Social Sciences). 2013;13(01):36\u201342.","journal-title":"Acta University Medicinals Nanjing (Social Sciences)"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2024.2403940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:41:39Z","timestamp":1772779299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2024.2403940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/13696998.2024.2403940"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2024.2403940","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}